Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00419081
Status:
TERMINATED
Last Update Posted:
2012-01-23
First Post:
2007-01-05
Brief Title:
Study of Forodesine Hydrochloride in Patients With RelapsedRefractory Precursor T-Lymphoblastic LeukemiaLymphoma Who Have Failed Two or More Prior Treatment Regimens
Sponsor:
BioCryst Pharmaceuticals
Organization:
BioCryst Pharmaceuticals
Organization Data
Organization:
BioCryst Pharmaceuticals
Class:
INDUSTRY
Study ID:
BCX1777-Tio-05-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioCryst Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None